AIMS: Primary percutaneous coronary intervention (PPCI) is the preferred reperfusion therapy in ST-elevation myocardial infarction (STEMI). We conducted this study to evaluate the contemporary status on the use and type of reperfusion therapy in patients admitted with STEMI in the European Society of Cardiology (ESC) member countries. METHODS AND RESULTS: A cross-sectional descriptive study based on aggregated country-level data on the use of reperfusion therapy in patients admitted with STEMI during 2010 or 2011. Thirty-seven ESC countries were able to provide data from existing national or regional registries. In countries where no such registries exist, data were based on best expert estimates. Data were collected on the use of STEMI reperfusion treatment and mortality, the numbers of cardiologists, and the availability of PPCI facilities in each country. Our survey provides a brief data summary of the degree of variation in reperfusion therapy across Europe. The number of PPCI procedures varied between countries, ranging from 23 to 884 per million inhabitants. Primary percutaneous coronary intervention and thrombolysis were the dominant reperfusion strategy in 33 and 4 countries, respectively. The mean population served by a single PPCI centre with a 24-h service 7 days a week ranged from 31 300 inhabitants per centre to 6 533 000 inhabitants per centre. Twenty-seven of the total 37 countries participated in a former survey from 2007, and major increases in PPCI utilization were observed in 13 of these countries. CONCLUSION: Large variations in reperfusion treatment are still present across Europe. Countries in Eastern and Southern Europe reported that a substantial number of STEMI patients are not receiving any reperfusion therapy. Implementation of the best reperfusion therapy as recommended in the guidelines should be encouraged.

3rd Department of Internal Medicine Cardiology and Emergency Medicine Wilhelminen Hospital Vienna Austria

Alexandra Hospital Department of Clinical Therapeutics University of Athens Athens Greece

AMIS Plus Data Center Institute of Social and Preventive Medicine University of Zurich Zurich Switzerland

BH Heart Center Tuzla Bosnia and Herzegovina

Cardiac Centre University Hospital of J A Reiman Prešov Slovakia

Cardiocenter 3rd Faculty of Medicine Charles University Prague Prague Czech Republic

Cardiology Department University Hospitals Birmingham NHS Foundation Trust Birmingham UK

Cardiovascular Biomedical Research Unit Royal Brompton Hospital London UK

Cardiovascular Center Aalst OLV Hospital Aalst Belgium

Cardiovascular Diseases Institute 'C C Iliescu' Bucharest Romania

Clinique Pasteur Toulouse France

Department of Cardiac Sciences King Fahad Cardiac Center College of Medicine King Saud University Riyadh Kingdom of Saudi Arabia

Department of Cardiology Aarhus University Hospital Brendstrupgaardsvej 100 Skejby DK 8200 Aarhus N Denmark

Department of Cardiology and Cardiovascular Interventions University Hospital Jagiellonian University Krakow Poland

Department of Cardiology and Cardiovascular Research Center Landspitali University Hospital of Iceland Reykjavik Iceland

Department of Cardiology and Uppsala Clinical Research Center Uppsala University Uppsala Sweden

Department of Cardiology Belinson and Hasharon Hospitals Petach Tikva and 'Sackler' Facultu of Medicine Tel Aviv University Tel Aviv Israel

Department of Cardiology CHRU La Cavale Blance Brest Cedex France

Department of Cardiology Clinic Thorax Institute Hospital Clinic de Barcelona Barcelona Spain

Department of Cardiology Copenhagen University Hospital Gentofte Hellerup Denmark

Department of Cardiology Institute for Cardiovascular Diseases Clinical Centre of Serbia Belgrade Serbia

Department of Cardiology Larnaca General Hospital Larnaca Cyprus

Department of Cardiology Medical Faculty Bezmialem Vakif University Istanbul Turkey

Department of Cardiology Rigshospitalet University of Copenhagen Copenhagen Denmark

Department of Cardiology UMC St Radboud Nijmegen Hearth Lung Center Nijmegen The Netherlands

Department of Cardiology University Hospital 'St Ekaterina' Sofia Bulgaria

Department of Cardiology University Hospital Antwerp Antwerp Belgium

Department of Cardiovascular Diseases University of Zagreb School of Medicine University Hospital Centre Zagreb Zagreb Croatia

Department of Health Economics Medical School Hamburg Hamburg Germany

Department of Internal Cardiovascular Medicine Masaryk University and University Hospital Brno Brno Czech Republic

Department of Public Health Health Service Executive Dublin Ireland

Division of Cardiology Cardiovascular Department Ospedali Riuniti Bergamo Italy

Division of Cardiology Department of Internal Medicine Ospedale di Stato San Marino Republic of San Marino

Heart Center Co Tampere University Hospital Tampere Finland

Myocardial Infarction Department Cardiology Research Institute Baku Azerbaijan

National Scientific Center 'the MD Strazhesko Institute of Cardiology' Academy of Medical Science of Ukraine Kiev Ukraine

Semmelweis University Heart Center Budapest Hungary

SFL Contact Person in Geogia 0105 Tbilisi Georgia

SFL Egypt Champion Faculty of Medicine Alexandria University Alexandria Egypt

SFL Portugal Champion Association of Cardiovascular Intervention Portugese Society of Cardiology Lisbon Portugal

Stent for Life Initiative UK European Association of Percutaneous Cardiovascular Interventions The European Heart House France

University Clinic of Cardiology Department of Interventional Cardiology University St Cyril and Methodius Skopje Marcedonia

University Hospital 1st Medical School Charles University Prague Prague Czech Republic

University Medical Center Ljubljana Slovenia

University of Latvia Pauls Stradins Clinical University Hospital Riga Latvia

Eur Heart J. 2014 Oct 7;35(38):2697 PubMed

Citace poskytuje Crossref.org

European Society of Cardiology ST-segment Elevation Myocardial Infarction Guidelines in Perspective - Focused on Primary Percutaneous Coronary Intervention